IP Verse

Optimised Injection Formulation For Mrna

PatentPatent Analysis

EP3153179

CUREVAC
Application Number
EP16001381A
Filing Date
May 19, 2006
Status
Opposition Rejected
Oct 25, 2024
Grant Date
Jun 19, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3283059B1
EP4155409B1
EP4108769B1

Bibliography

The patent EP3153179B1 was granted to Curevac on Jun 19, 2019 following the initial filing on May 19, 2006 under the application number EP16001381A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ETHERNA IMMUNOTHERAPIESMar 18, 2020ADMISSIBLE
BIONTECHMar 16, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents